Table 2.
Prescribing frequency for each identified PIM according to the Swedish quality indicators and the EU (7)-PIM list
| ATC code | Drug class/name (ATC code) | Prescriptions, n (col%) Swedish quality indicators | Prescriptions, n (col%) EU (7)-PIM list |
|---|---|---|---|
| A03F | Medications for functional gastrointestinal disorder—propulsives | n/a | 1 (1.6%) |
| Metoclopramide (A03FA01) | n/a | 1 (1.6%) | |
| A06A | Laxatives | n/a | 3 (4.7%) |
| Sodium picosulfate (A06AB08) | n/a | 3 (4.7%) | |
| A 10 | Blood glucose lowering medications, excl. insulins | n/a | 2 (3.1%) |
| Glibenclamide (A10BB01) | 1 (5.9%) | 1 (1.6%) | |
| Glipizide (A10BB07) | n/a | 1 (1.6%) | |
| B01A | Antithrombotic agents | n/a | 11 (17.2%) |
| Rivaroxaban (B01AF01) | n/a | 1 (1.6%) | |
| Apixaban (B01AF02) | n/a | 10 (15.6%) | |
| C01 | Cardiac therapy | n/a | 8 (12.5%) |
| Digoxin (C01AA05) | n/a | 4 (6.3%) | |
| Amiodarone (C01BD01) | n/a | 4 (6.3%) | |
| C02 | Antihypertensive therapy | n/a | 1 (1.6%) |
| Doxazosin (C02CA04) | n/a | 1 (1.6%) | |
| C03D | Diuretics, potassium-sparing agents | n/a | 5 (7.8%) |
| Spironolactone (> 25 mg/days) | n/a | 5 (7.8%) | |
| C07 | Betablocking agents | n/a | 1 (1.6%) |
| Sotalol (C07AA07) | n/a | 1 (1.6%) | |
| C08 | Calcium channel blockers | n/a | 1 (1.6%) |
| Diltiazem (C08DB01) | n/a | 1 (1.6%) | |
| G03C | Oestrogens (oral) | n/a | 2 (3.1%) |
| Estradiol (G03CA03) | n/a | 1 (1.6%) | |
| Estriol (G03CA04) | n/a | 1 (1.6%) | |
| G04 | Other urologicals, incl. antispasmodic medications | n/a | 2 (3.1%) |
| Tolterodine (G04BD07)a | 1 (5.9%) | 1 (1.6%) | |
| Solifenacin (G04BD08)a | 1 (5.9%) | 1 (1.6%) | |
| M01A | NSAID | 5 (29.4%) | 4 (6.3%) |
| Diclofenac (M01AB05) | 4 (23.5%) | 4 (6.3%) | |
| Naproxen (M01AE02) | 1 (5.9%) | n/a | |
| N02 | Analgesics—opioids | n/a | 3 (4.7%) |
| Codeine (N02AJ06) | 1 (5.9%) | n/a | |
| Tramadol (N02AX02) | 3 (17.6%) | 3 (4.7%) | |
| N03A | Antiepileptics | n/a | 1 (1.6%) |
| Carbamazepine (N03AF01) | n/a | 1 (1.6%) | |
| N04 | Antiparkinson medications | n/a | 2 (3.1%) |
| Pramipexole (N04BC05) | n/a | 2 (3.1%) | |
| N05A | Antipsychotics | 1 (5.9%) | 1 (1.6%) |
| Flupentixol (N05AF01) | 1 (5.9%) | 1 (1.6%) | |
| N05B | Anxiolytic medications | n/a | 2 (3.1%) |
| Hydroxyzine (N05BB01)a | 1 (5.9%) | 1 (1.6%) | |
| Diazepam (N05BA01) | 1 (5.9%) | 1 (1.6%) | |
| N05C | Hypnotics and sedatives | n/a | 12 (18.8%) |
| Zopiclone (N05CF01) > 3.75 mg/days | n/a | 9 (14.1%) | |
| Zolpidem (N05CF02) > 5 mg/days | n/a | 1 (1.6%) | |
| Clomethiazole (N05CM02) | n/a | 1 (1.6%) | |
| Propiomazine (N05CM06) | 1 (5.9%) | 1 (1.6%) | |
| N06A | Antidepressants | n/a | 2 (3.1%) |
| Amitriptyline (N06AA09)a | 1 (5.9%) | 1 (1.6%) | |
| Venlafaxine (N06AX16) | n/a | 1 (1.6%) |
aAnticholinergic medications according to Swedish quality indicators [in total 4 (23.5%) prescriptions]